Epidemiology, pathophysiology, and the future of ocular toxoplasmosis

Ocular Immunology and Inflammation

Volumn 22, Issue 2, 2014, Pages 138-147

  Kijlstra, Aize ^a,b   Petersen, Eskild ^c  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Drinking water; Gene polymorphism; Immunogenetics; Meat; Parasite strain; Parasite virulence; Toxoplasma gondii; Toxoplasmosis

Indexed keywords

ABC TRANSPORTER; BIOLOGICAL MARKER; DRINKING WATER; FRESH WATER; GAMMA INTERFERON; HLA B27 ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; PARASITE ANTIGEN; PURINERGIC P2X7 RECEPTOR; SEA WATER; SURFACE WATER; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 9; TOXOPLASMA GONDII VACCINE; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; VIRULENCE FACTOR;

ANIMAL WELFARE; AQUEOUS HUMOR; ARTICLE; CHORIORETINITIS; CONGENITAL TOXOPLASMOSIS; CYST (RESTING STAGE); DEVELOPING COUNTRY; DIAGNOSTIC PROCEDURE; DIETARY INTAKE; DISEASE COURSE; FUTUROLOGY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOMICS; HEREDITY; HLA SYSTEM; HOST PARASITE INTERACTION; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PARASITE IDENTIFICATION; PARASITE LOAD; PARASITE TRANSMISSION; PARASITE VIRULENCE; PATHOGENESIS; PATHOPHYSIOLOGY; PREVALENCE; PROTEOMICS; QUALITY OF LIFE; RETINA IMAGE; RETINA INJURY; RETINITIS; RISK FACTOR; SEROPREVALENCE; SEROTYPING; SWIMMING; TACHYZOITE; TOXOPLASMA GONDII; TOXOPLASMOSIS; UVEITIS; VERTICAL TRANSMISSION; WATER SUPPLY; ANIMAL; DIFFERENTIAL DIAGNOSIS; HEALTH; INCIDENCE; ISOLATION AND PURIFICATION; PARASITOLOGY; PROGNOSIS; TOXOPLASMA; TOXOPLASMOSIS, OCULAR;

ANIMALS; DIAGNOSIS, DIFFERENTIAL; GLOBAL HEALTH; HUMANS; INCIDENCE; PREVALENCE; PROGNOSIS; TOMOGRAPHY, OPTICAL COHERENCE; TOXOPLASMA; TOXOPLASMOSIS, OCULAR;

EID: 84897530517     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273948.2013.823214     Document Type: Article

References (103)

1. Bosch-Driessen LEH, Berendschot T, Ongkosuwito JV, et al. Ocular toxoplasmosis: Clinical features and prognosis of 154 patients. Ophthalmology 2002;109:869-878
2. Holland GN. LX Edward Jackson memorial lecture: Ocular toxoplasmosis-A global reassessment, part 1: Epidemiology and course of disease. Am J Ophthalmol. 2003;136: 973-988
3. Kirby T. Calls for more detailed studies on toxoplasmosis. Lancet Infect Dis. 2012;12:912-913
4. Vaudaux JD, Muccioli C, James ER, et al. Identification of an atypical strain of Toxoplasma gondii as the cause of a waterborne outbreak of toxoplasmosis in Santa Isabel do Ivai, Brazil. J Infect Dis. 2010;202:1226-1233
5. Vasconcelos-Santos DV. Ocular manifestations of systemic disease: Toxoplasmosis. Curr Opin Ophthalmol. 2012;23: 543-550
6. Wakefield D, Cunningham ET, Pavesio C, et al. Controversies in ocular toxoplasmosis. Ocul Immunol Inflamm. 2011;19:2-9
7. Vasconcelos-Santos DV, Dodds EM, Orefice F. Review for disease of the year: Differential diagnosis of ocular toxoplasmosis. Ocul Immunol Inflamm. 2011;19:171-179
8. Garweg JG, de Groot-Mijnes JDF, Montoya JG. Diagnostic approach to ocular toxoplasmosis. Ocul Immunol Inflamm. 2011;19:255-261
9. Petersen E, Kijlstra A, Stanford M Epidemiology of ocular toxoplasmosis. Ocul Immunol Inflamm. 2012;20:68-75
10. Silveira C, Ferreira R, Muccioli C, et al. Toxoplamosis transmitted to a newborn from the mother infected 20 years earlier. Am J Ophthalmol. 2003;136:370-371
11. Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: From animals to humans. Int J Parasitol. 2000;30:1217-1258
12. Popkin BM. Nutrition in transition: The changing global nutrition challenge. Asia Pacific J Clin Nutr. 2001;10: S13-S18
13. Kijlstra A, Meerburg BG, Mul MF. Animal-friendly production systems may cause re-emergence of Toxoplasma gondii. Njas-Wageningen J Life Sci. 2004;52:119-132
14. Kijlstra A, Jongert E. Control of the risk of human toxoplasmosis transmitted by meat. Int J Parasitol. 2008; 38:1359-1370
15. Meerburg BG, Kijlstra A. Changing climate-changing pathogens: Toxoplasma gondii in North-Western Europe. Parasitol Res. 2009;105:17-24
16. Peixoto-Rangel AL, Miller EN, Castellucci L, et al. Candidate gene analysis of ocular toxoplasmosis in Brazil: Evidence for a role for toll-like receptor 9 (TLR9). Mem Instit Oswaldo Cruz. 2009;104:1187-1190
17. Dutra MS, Bela SR, Peixoto-Rangel AL, et al. Association of a NOD2 gene polymorphism and T-helper 17 cells with presumed ocular toxoplasmosis. J Infect Dis. 2013;207: 152-163
18. Su CL, Khan A, Zhou P, et al. Globally diverse Toxoplasma gondii isolates comprise six major clades originating from a small number of distinct ancestral lineages. Proc Natl Acad Sci U S A. 2012;109:5844-5849
19. Demar M, Ajzenberg D, Maubon D, et al. Fatal outbreak of human toxoplasmosis along the Maroni River: Epidemiological, clinical, and parasitological aspects. Clin Infect Dis. 2007;45:E88-E95
20. Cook AJC, Gilbert RE, Buffolano W, et al. Sources of toxoplasma infection in pregnant women: European multicentre case-control study. Br Med J. 2000;321:142-147
21. Bahia-Oliveira LMG, Jones JL, Azevedo-Silva J, et al. Highly endemic, waterborne toxoplasmosis in north Rio de Janeiro state, Brazil. Emerg Infect Dis. 2003;9:55-62
22. Frenkel JK, Ruiz A, Chinchilla M Soil survival of Toxoplasma oocysts in Kansas and Costa Rica. Am J Trop Med Hyg. 1975;24:439-443
23. Dumetre A, Le Bras C, Baffet M, et al. Effects of ozone and ultraviolet radiation treatments on the infectivity of Toxoplasma gondii oocysts. Vet Parasitol. 2008;153:209-213
24. Hijnen WAM, Brouwer-Hanzens AJ, Charles KJ, et al. Transport of MS2 phage, Escherichia coli, Clostridium perfringens, Cryptosporidium parvum and Giardia intestinalis in a gravel and a sandy soil. Environ Sci Technol. 2005;39: 7860-7868
25. Karanis P, Aldeyarbi HM, Mirhashemi ME, et al. The impact of the waterborne transmission of Toxoplasma gondii and analysis efforts for water detection: An overview and update. Environ Sci Pollut Res. 2013;20:86-99
26. Karanis P, Kourenti C, Smith HWaterborne transmission of protozoan parasites: A worldwide review of outbreaks and lessons learnt. J Water Health 2007;5:1-38
27. Frenkel JK, Pfefferkorn ER, Smith DD, et al. Prospective vaccine prepared from a new mutant of Toxoplasma gondii for use in cats. Am J Vet Res. 1991;52:759-763
28. Mateus-Pinilla NE, Dubey JP, Choromanski L, et al. A field trial of the effectiveness of a feline Toxoplasma gondii vaccine in reducing T. gondii exposure for swine. J Parasitol. 1999;85:855-860
29. Lass A, Pietkiewicz H, Szostakowska B, et al. The first detection of DNA in environmental fruits and vegetables samples. Eur J Clin Microbiol Infect Dis. 2012;31:1101-1108
30. Alvarado-Esquivel C, Estrada-Martinez S, Liesenfeld O Toxoplasma gondii infection in workers occupationally exposed to unwashed raw fruits and vegetables: A case control seroprevalence study. Parasites Vectors. 2011; 4:235
31. Shapiro K, Miller M, Mazet J, et al. Effect of estuarine wetland degradation on transport of Toxoplasma gondii surrogates from land to sea. Appl Environ Microbiol. 2010; 76:6821-6828
32. Shapiro K, Miller M, Mazet J Temporal association between land-based runoff events and California sea otter (Enhydra lutris nereis) protozoal mortalities. J Wildlife Dis. 2012;48: 394-404
33. Robertson LJ. The potential for marine bivalve shellfish to act as transmission vehicles for outbreaks of protozoan infections in humans: A review. Int J Food Microbiol. 2007; 120:201-216
34. Chiang TY, Hsieh HH, Kuo MC, et al. Seroepidemiology of Toxoplasma gondii infection among healthy blood donors in Taiwan. Plos One 2012;7:e48139
35. Pappas G, Roussos N, Falagas ME. Toxoplasmosis snapshots: Global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol. 2009;39:1385-1394
36. Hill D, Coss C, Dubey JP, et al. Identification of a sporozoite-specific antigen from Toxoplasma gondii. J Parasitol. 2011;97:328-337
37. Boyer K, Hill D, Mui E, et al. Unrecognized ingestion of Toxoplasma gondii oocysts leads to congenital toxoplasmosis and causes epidemics in North America. Clin Infect Dis. 2011;53:1081-1089
38. Fan CK, Lee LW, Liao CW, et al. Toxoplasma gondii infection: Relationship between seroprevalence and risk factors among primary schoolchildren in the capital areas of Democratic Republic of Sao Tome and Principe, West Africa. Parasite Vectors. 2012;5:141
39. Havelaar AH, Haagsma JA, Mangen MJJ, et al. Disease burden of foodborne pathogens in the Netherlands, 2009. Int J Food Microbiol. 2012;156:231-238
40. Gilbert RE, Stanford MR. Is ocular toxoplasmosis caused by prenatal or postnatal infectioñ. Br J Ophthalmol. 2000; 84:224-226
41. Dubey JP, Lago EG, Gennari SM, et al. Toxoplasmosis in humans and animals in Brazil: High prevalence, high burden of disease, and epidemiology. Parasitology. 2012; 139:1375-1424
42. Hofhuis A, Van Pelt W, Van Duynhoven Y, et al. Decreased prevalence and age-specific risk factors for Toxoplasma gondii IgG antibodies in The Netherlands between 1995/ 1996 and 2006/2007. Epidemiol Infect. 2011;139:530-538
43. Kortbeek LM, Hofhuis A, Nijhuis CDM, et al. Congenital toxoplasmosis and DALYs in the Netherlands. Mem Instit Oswaldo Cruz. 2009;104:370-373
44. Lachenmaier SM, Deli MA, Meissner M, et al. Intracellular transport of Toxoplasma gondii through the blood-brain barrier. J Neuroimmunol. 2011;232:119-130
45. Furtado JM, Bharadwaj AS, Chipps TJ, et al. Toxoplasma gondii tachyzoites cross retinal endothelium assisted by intercellular adhesion molecule-1 in vitro. Immunol Cell Biol. 2012;90:912-915
46. Furtado JM, Ashander LM, Mohs K, et al. Toxoplasma gondii migration within and infection of human retina. Plos One. 2013;8:e54358
47. Silveira C, Vallochi AL, da Silva UR, et al. Toxoplasma gondii in the peripheral blood of patients with acute and chronic toxoplasmosis. Br J Ophthalmol. 2011;95:396-400
48. Dubey JP. The history of Toxoplasma gondii: The first 100 years. J Eukaryotic Microbiol. 2008;55:467-475
49. Lambert H, Dellacasa-Lindberg I, Barragan A. Migratory responses of leukocytes infected with Toxoplasma gondii. Microbes Infect. 2011;13:96-102
50. Lambert H, Hitziger N, Dellacasa I, et al. Induction of dendritic cell migration upon Toxoplasma gondii infection potentiates parasite dissemination. Cell Microbiol. 2006;8: 1611-1623
51. Lambert H, Vutova PP, Adams WC, et al. The Toxoplasma gondii-shuttling function of dendritic cells is linked to the parasite genotype. Infect Immun. 2009;77:1679-1688
52. Fuks JM, Arrighi RBG, Weidner JM, et al. GABAergic signaling is linked to a hypermigratory phenotype in dendritic cells infected by Toxoplasma gondii. Plos Pathogens. 2012;8:e1003051
53. Courret N, Darche S, Sonigo P, et al. CD11c-And CD11bexpressing mouse leukocytes transport single Toxoplasma gondii tachyzoites to the brain. Blood. 2006;107:309-316
54. Furtado JM, Bharadwaj AS, Ashander LM, et al. Migration of Toxoplasma gondii-infected dendritic cells across human retinal vascular endothelium. Invest Ophthalmol Vis Sci. 2012;53:6856-6862
55. Yang PZ, Das PK, Kijlstra A. Localization and characterization of immunocompetent cells in the human retina. Ocul Immunol Inflamm. 2000;8:149-157
56. Chen L, Yang PZ, Kijlstra A. Distribution, markers, and functions of retinal microglia. Ocul Immunol Inflamm. 2002; 10:27-39
57. Weidner JM, Kanatani S, Hernandez-Castaneda MA, et al. Rapid cytoskeleton remodelling in dendritic cells following invasion by Toxoplasma gondii coincides with the onset of a hypermigratory phenotype. Cell Microbiol. 2013;in press
58. Flegr J. How and why Toxoplasma makes us crazy. Trends Parasitol. 2013;29:156-163
59. Duarte J, Pacheco MTT, Villaverde AB, et al. Near-infrared Raman spectroscopy to detect anti-Toxoplasma gondii antibody in blood sera of domestic cats: Quantitative analysis based on partial least-squares multivariate statistics. J Biomed Optics. 2010;15:047002
60. Araujo-Andrade C, Pichardo-Molina JL, Barbosa-Sabanero G, et al. Detection of the presence of antibodies against Toxoplasma gondii in human colostrum by Raman spectroscopy and principal component analysis. J Biomed Optics. 2007;12:034006
61. Erckens RJ, Jongsma FHM, Wicksted JP, et al. Raman spectroscopy in ophthalmology: From experimental tool to applications in vivo. Lasers Med Sci. 2001;16:236-252
62. Elshout M, Erckens RJ, Webers CA, et al. Detection of Raman spectra in ocular drugs for potential in vivo application of Raman spectroscopy. J Ocul Pharmacol Therapeut. 2011;27:445-451
63. Du LP, Kijlstra A, Yang PZ. Immune response genes in uveitis. Ocul Immunol Inflamm. 2009;17:249-256
64. Hou S, Kijlstra A, Yang P. The genetics of Behcet's disease in a Chinese population. Front Med. 2012;6:354-359
65. Nussenblatt RB, Mittal KK, Fuhrman S, et al. Lymphocyte proliferative responses of patients with ocular toxoplasmosis to parasite and retinal antigens. Am J Ophthalmol. 1989;107:632-641
66. Meenken C, Rothova A, Dewaal LP, et al. HLA typing in congenital toxoplasmosis. Br J Ophthalmol. 1995;79:494-497
67. Holland GN, Cornell PJ, Park MS, et al. An association between acute retinal necrosis syndrome and HLA-DQW7 and phenotype-BW62,DR4. Am J Ophthalmol. 1989;108: 370-374
68. Subauste CS, Ajzenberg D, Kijlstra A. Review of the series disease of the year 2011: Toxoplasmosis pathophysiology of toxoplasmosis. Ocul Immunol Inflamm. 2011;19:297-306
69. Henriquez FL, Woods S, Cong H, et al. Immunogenetics of Toxoplasma gondii informs vaccine design. Trends Parasitol. 2010;26:550-555
70. Suzuki Y. Host resistance in the brain against Toxoplasma gondii. J Infect Dis. 2002;185:S58-S65
71. Jamieson SE, de Roubaix LA, Cortina-Borja M, et al. Genetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital toxoplasmosis. Plos One. 2008;3:e2285
72. Jamieson SE, Cordell H, Petersen E, et al. Host genetic and epigenetic factors in toxoplasmosis. Mem Instit Oswaldo Cruz. 2009;104:162-169
73. Cordeiro CA, Moreira PR, Costa GC, et al. Interleukin-1 gene polymorphisms and toxoplasmic retinochoroiditis. Mol Vision. 2008;14:1845-1849
74. Cordeiro CA, Moreira PR, Bessa TF, et al. Interleukin-6 gene polymorphism (-174 G/C) is associated with toxoplasmic retinochoroiditis. Acta Ophthalmol. 2013;91: E311-314
75. Cordeiro CA, Moreira PR, Andrade MS, et al. Interleukin-10 gene polymorphism (-1082G/A) is associated with toxoplasmic retinochoroiditis. Invest Ophthalmol Vis Sci. 2008;49:1979-1982
76. Neves ED, Curi ALL, de Albuquerque MC, et al. Genetic polymorphism for IFN gamma874T/A in patients with acute toxoplasmosis. Rev Soc Brasileira Med Trop. 2012;45: 757-760
77. Jamieson SE, Peixoto-Rangel AL, Hargrave AC, et al. Evidence for associations between the purinergic receptor P2X(7) (P2RX7) and toxoplasmosis. Genes Immun. 2010;11: 374-383
78. Miller CM, Boulter NR, Fuller SJ, et al. The role of the P2X(7) receptor in infectious diseases. Plos Pathogens. 2011; 7:e1002212
79. Witola WH, Mui E, Hargrave A, et al. NALP1 Influences susceptibility to human congenital toxoplasmosis, proinflammatory cytokine response, and fate of Toxoplasma gondii-infected monocytic cells. Infect Immun. 2011;79: 756-766
80. Bessa TF, Cordeiro CA, Goncalves RM, et al. Increased serum levels of soluble tumor necrosis factor receptor-2 (sTNFR2) in patients with active toxoplasmic retinochoroiditis. Brazilian J Infect Dis. 2012;16:540-544
81. Jay NL, Gillies M. Proteomic analysis of ophthalmic disease. Clin Exp Ophthalmol. 2012;40:755-763
82. Seeber F, Boothroyd JC. Escherichia coli beta-galactosidase as an in vitro and in vivo reporter enzyme and stable transfection marker in the intracellular protozoan parasite Toxoplasma gondii. Gene. 1996;169:39-45
83. McMenamin PG. Optimal methods for preparation and immunostaining of iris, ciliary body, and choroidal wholemounts. Invest Ophthalmol Vis Sci. 2000;41: 3043-3048
84. Escoffier P, Jeanny JC, Marinach-Patrice C, et al. Toxoplasma gondii: Flat-mounting of retina as a new tool for the observation of ocular infection in mice. Exp Parasitol. 2010;126:259-262
85. McMenamin PG, Dutton GN, Hay J, et al. The ultrastructural pathology of congenital murine toxoplasmic retinochoroiditis, 1: The localization and morphology of Toxoplasma cysts in the retina. Exp Eye Res. 1986;43: 529-543
86. Garweg JG, de Kozak Y, Goldenberg B, et al. Anti-retinal autoantibodies in experimental ocular and systemic toxoplasmosis. Graefes Arch Clin Exp Ophthalmol. 2010;248: 573-584
87. Holland GN. LX Edward Jackson Memorial Lecture: Ocular toxoplasmosis-A global reassessment, part II: Disease manifestations and management. Am J Ophthalmol. 2004; 137:1-17
88. Pifer R, Yarovinsky F Innate responses to Toxoplasma gondii in mice and humans. Trends Parasitol. 2011;27:388-393
89. Lahmar I, Guinard M, Sauer A, et al. Murine neonatal infection provides an efficient model for congenital ocular toxoplasmosis. Exp Parasitol. 2010;124:190-196
90. Wallon M, Peyron F, Cornu C, et al. Congenital Toxoplasma infection: Monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years. Clin Infect Dis. 2013;56:1223-1231
91. Mimura KK, Tedesco RC, Calabrese KS, et al. The involvement of anti-inflammatory protein, annexin A1, in ocular toxoplasmosis. Mol Vis. 2012;18:1583-1593
92. Hitziger N, Dellacasa I, Albiger B, et al. Dissemination of Toxoplasma gondii to immunoprivileged organs and role of Toll/interleukin-1 receptor signalling for host resistance assessed by in vivo bioluminescence imaging. Cell Microbiol. 2005;7:837-848
93. Pissuwan D, Valenzuela SM, Miller CM, et al. A golden bullet? Selective targeting of Toxoplasma gondii tachyzoites using anti body-functionalized gold nanorods. Nano Lett. 2007;7:3808-3812
94. Cense B, Gao WH, Brown JM, et al. Retinal imaging with polarization-sensitive optical coherence tomography and adaptive optics. Opt Express. 2009;17:21634-21651
95. Desmettre T, Labalette P, Fortier B, et al. Laser photocoagulation around the foci of Toxoplasma retinochoroiditis: A descriptive statistical analysis of 35 patients with long-Term follow-up. Ophthalmologica. 1996;210:90-94
96. Orefice JL, Costa RA, Scott IU, et al. Spectral optical coherence tomography findings in patients with ocular toxoplasmosis and active satellite lesions (MINAS Report 1). Acta Ophthalmol. 2013;91:e41-e47
97. Robert-Gangneux F, Darde ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev. 2012;25:264-296
98. Grigg ME, Ganatra J, Boothroyd JC, et al. Unusual abundance of atypical strains associated with human ocular toxoplasmosis. J Infect Dis. 2001;184:633-639
99. Fentress SJ, Steinfeldt T, Howard JC, et al. The argininerich N-Terminal domain of ROP18 is necessary for vacuole targeting and virulence of Toxoplasma gondii. Cell Microbiol. 2012;14:1921-1933
100. Smith JR, Franc DT, Carter NS, et al. Susceptibility of retinal vascular endothelium to infection with Toxoplasma gondii tachyzoites. Invest Ophthalmol Vis Sci. 2004;45: 1157-1161
101. Dubremetz JF, Lebrun M. Virulence factors of Toxoplasma gondii. Microbes Infect. 2012;14:1403-1410
102. Kong JT, Grigg ME, Uyetake L, et al. Serotyping of Toxoplasma gondii infections in humans using synthetic peptides. J Infect Dis. 2003;187:1484-1495
103. McLeod R, Boyer KM, Lee D, et al. Prematurity and severity are associated with Toxoplasma gondii alleles (NCCCTS, 1981-2009). Clin Infect Dis. 2012;54:1595-1605